Q:

What is the advantage of the 96-well Shuttleâ„¢ Device over common lipofection, especially in a high throughput framework?

A:

Several primary cells of high research relevance can simply not be transfected at relevant efficiencies and viabilities using lipofection. The same holds true for many suspension cell lines which are often used for protein production. These difficult to transfect cells can be easily transfected using the Nucleofectorâ„¢ Technology which allows for screening operations using highly significant primary cells.

Categories:
Transfection